You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

janus kinase

Showing 26 - 50 of 2,152
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Inpatient COVID-19 Treatments

Active, not recruiting
  • COVID-19
  • Initiation of IL6Ri (tocilizumab or sarilumab) versus JAKi (baricitinib or tofacitinib) added to systemic corticosteroids of interest (CSI)
  • New York, New York
    Aetion, Inc.
Jan 12, 2023

Lupus Nephritis Trial in Assiut (Anti JAK1,2)

Active, not recruiting
  • Lupus Nephritis
  • Anti JAK1,2
  • Assiut, Assuit, Egypt
    Manal Hassanien
Jun 21, 2022

JAK Inhibition in Ulcerative Colitis

Not yet recruiting
  • Analyzing Immune Composition Changes Upon JAK Inhibitor Treatment of Ulcerative Colitis Patients
  • JAK inhibitor treatment
  • (no location specified)
Jul 11, 2022

JAK-STAT Signaling Pathway in Pyoderma Gangrenosum

Not yet recruiting
  • Pyoderma Gangrenosum
  • +2 more
  • immunohistochemical methods
  • (no location specified)
Mar 21, 2022

Atopic Dermatitis Trial in Netherlands

Recruiting
  • Atopic Dermatitis
    • Leeuwarden, Friesland, Netherlands
    • +13 more
    May 18, 2022

    Acneiform Eruptions Trial in Shanghai (Cream containing JAK Inhibitor)

    Recruiting
    • Acneiform Eruptions
    • Cream containing JAK Inhibitor
    • Shanghai, Shanghai, China
      Shanghai East Hospital
    Jun 20, 2022

    Axial Spondyloarthritis Trial in Dhaka (Baricitinib 2mg, Tofacitinib 5 mg)

    Recruiting
    • Axial Spondyloarthritis
    • Baricitinib 2mg
    • Tofacitinib 5 mg
    • Dhaka, Bangladesh
      Bangabandhu Sheikh Mujib Medical University
    Nov 1, 2023

    Rheumatoid Arthritis Trial in Leeds (Tocilizumab, Methotrexate)

    Completed
    • Rheumatoid Arthritis
    • Leeds, West Yorkshire, United Kingdom
      Leeds Teaching Hospitals NHS Trust
    Nov 5, 2019

    Myelofibrosis Trial in Jinan (TQ05105 tablets, Itraconazole capsule, Rifampicin Capsule)

    Not yet recruiting
    • Myelofibrosis
    • TQ05105 tablets
    • +2 more
    • Jinan, Shandong, China
      Shandong Provincial Hospital
    Aug 30, 2023

    Ruxolitinib in Patients With Myelofibrosis

    Not yet recruiting
    • Myelofibrosis
    • (no location specified)
    Feb 28, 2023

    Alopecia Areata Trial in Bangkok (Tofacitinib)

    Completed
    Has Results
    • Alopecia Areata
    • Bangkok, Thailand
      Institute of Dermatology
    Mar 28, 2022

    Eosinophilic Myeloid Tumor, Hypereosinophilic Syndrome Trial run by the National Institute of Allergy and Infectious Diseases

    Recruiting
    • Eosinophilic Myeloid Neoplasm
    • Hypereosinophilic Syndrome
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Dermatomyositis Trial in Paris (Baricitinib, Placebo)

    Not yet recruiting
    • Dermatomyositis
    • Paris, France
      Pitie-Salpêtrière hospital APHP
    Jun 7, 2022

    Myelofibrosis Trial in China (TQ05105 Tablets, TQB3617 Capsules)

    Not yet recruiting
    • Myelofibrosis
    • TQ05105 Tablets
    • TQB3617 Capsules
    • Guangzhou, Guangdong, China
    • +19 more
    Nov 7, 2023

    Cutaneous Sarcoidosis, Granuloma Annulare Trial in New Haven (Tofacitinib 5 mg twice daily)

    Completed
    • Cutaneous Sarcoidosis
    • Granuloma Annulare
    • Tofacitinib 5 mg twice daily
    • New Haven, Connecticut
      Yale Center for Clinical Investigation
    Jul 13, 2021

    Vitiligo, Generalized Trial (Baricitinib)

    Not yet recruiting
    • Vitiligo, Generalized
    • (no location specified)
    Jul 7, 2023

    Quality of Life Trial in Baton Rouge (Dietary supplement)

    Recruiting
    • Quality of Life
    • Dietary supplement
    • Baton Rouge, Louisiana
      Pennington Biomedical Research Center
    Sep 13, 2022

    Asthma Trial in Worldwide (AZD4604, Placebo)

    Not yet recruiting
    • Asthma
    • Stockton, California
    • +24 more
    Aug 25, 2023

    Down Syndrome, Alopecia Areata, Atopic Dermatitis / Eczema Trial in Aurora (Tofacitinib)

    Recruiting
    • Down Syndrome
    • +5 more
    • Aurora, Colorado
      Linda Crnic Institute for Down Syndrome
    Jan 17, 2023

    Myelofibrosis Trial in Houston (Long-term Follow-up, Quality-of-Life Assessment, Ruxolitinib)

    Active, not recruiting
    • Myelofibrosis
    • Long-term Follow-up
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 7, 2022

    Vitiligo Trial (skin biopsy)

    Completed
    • Vitiligo
    • skin biopsy
    • (no location specified)
    Nov 30, 2018

    Traumatic Brain Injury Trial in Xi'an (Baricitinib 4 MG, Standard treatment)

    Not yet recruiting
    • Traumatic Brain Injury
    • Baricitinib 4 MG
    • Standard treatment
    • Xi'an, Shaanxi, China
      Tandu Hospital, Fourth Military Medical University
    Sep 26, 2023

    Immunoclassification, Psoriasis Trial in Hangzhou (adalimumab, secukinumab, ixekizumab, guselkumab, Jak inhibitors,

    Recruiting
    • Immunoclassification
    • Psoriasis
    • adalimumab, secukinumab, ixekizumab, guselkumab, Jak inhibitors, methotrexate
    • Hangzhou, Zhejiang, China
      2nd Affiliated Hospital, School of Medicine, Zhejiang University
    Aug 16, 2022

    Local and Systemic Immunoprofiling of Patients Diagnosed With

    Recruiting
    • Ulcerative Colitis Flare
      • Nijmegen, Gelderland, Netherlands
        RadboudUMC
      Jan 10, 2023

      Polycythemia Vera Trial in Italy (AOP2014, Phlebotomies, ASA)

      Active, not recruiting
      • Polycythemia Vera
      • San Giovanni Rotondo, (FG) Puglia, Italy
      • +22 more
      Jan 10, 2023